Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, Milena Barcza Stockler‐Pinto
Topics & Concepts
InflammationTLR4InflammasomePharmacologyToll-like receptorBiologyMedicineReceptorImmunologyInnate immune systemBiochemistryInflammasome and immune disordersImmune Response and InflammationIL-33, ST2, and ILC Pathways